Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial.

Human fertility (Cambridge, England) - 1 Dec 2008

Qublan H, Amarin Z, Dabbas M, Farraj A-E, Beni-Merei Z, Al-Akash H, Bdoor A-N, Nawasreh M, Malkawi S, Diab F, Al-Ahmad N, Balawneh M, Abu-Salim A

Abstract excerpt

INTRODUCTION: Recently, thrombophilia (acquired and inherited) has been implicated in recurrent IVF-ET failure. The objective of this study was to determine the effect and safety of thromboprophylaxis using low-molecular-weight heparin (LMWH) in women with recurrent in vitro fertilization (IVF)-e...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Embryo Implantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Embryo Transfer

Share to Factor V

Share to Fertilization in Vitro

Share to Patient Selection

Share to Pregnancy

Share to Thrombophilia

Source

Identifiers

PMID: 19085261
DOI: 10.1080/14647270801995431

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19085261-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial.PMID 19085261Read ↗

ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.Semantic proximity Read ↗

Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trialSemantic proximity Read ↗

Efficacy of the combined administration of low dose aspirin and low molecular weight heparin in unexplained recurrent miscarriages with occasional antiphospholipid antibody positivity: A case report and literature reviewSemantic proximity Read ↗

Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure.Semantic proximity Read ↗

Multiple Pregnancy Failures: An Immunological ParadigmSemantic proximity Read ↗

Pregnancy loss and thrombophilia: the elusive linkSemantic proximity Read ↗

Lessons From the EThIGII Trial: Proper Putative Benefit Assessment of Low-Molecular-Weight Heparin Treatment in M2/ANXA5 Haplotype Carriers.Semantic proximity Read ↗

Increased rates of thrombophilia in women with repeated IVF failures.Semantic proximity Read ↗

Low molecular weight heparin for the prevention of severe preeclampsia: where next?Semantic proximity Read ↗

Anticoagulation and in vitro fertilization and ovarian stimulationSemantic proximity Read ↗

[Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].Semantic proximity Read ↗

Embryo implantation after assisted reproductive procedures and maternal thrombophilia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.